USPTO serial 77923118
SWISSAIR
Reviewed by CopyMark Law Group
Reg. 4033161Status 710
- Filing date
- Status date
- Registration date
- Oct 4, 2011
- Examiner
- GRIFFIN, JAMES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SWISSAIR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James A. Long
JAMES A. LONG JIANQ CHYUN INTELLECTUAL PROPERTY7F-1, NO. 100, ROOSEVELT RD., SEC. 2TAIPEI, 100TAIWANGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines, pharmaceutical preparations, veterinary preparations, pharmaceutical products, chemical preparations for use in medicine, chemical preparations for medical science for use in or on the human or animal body, chemical products for curative purposes, namely, effective compounds, all of the foregoing for the treatment of infectious diseases, respiratory infections, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, autoimmune diseases, immunologic deficiency syndromes, cancer, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, neurological disorders, brain injury, spinal cord injury, seizure disorders; sanitary preparations for medical use; pharmaceutical products for treating rare diseases, namely, for the treatment of infectious diseases, respiratory infections, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, autoimmune diseases, immunologic deficiency syndromes, cancer, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, neurological disorders, brain injury, spinal cord injury, and seizure disorders; dietetic foods adapted for medical use; dietetic foods and beverages adapted for health care use and human and veterinary medical use; disinfectants for medical purposes; preparations for destroying vermin, fungicides, herbicides; diagnostics, namely, diagnostic preparations for medical and veterinary use; diagnostic agents for veterinary use, X-ray contrast agents for medical use, diagnostic agents for medical use, medical preparations for mouth care, medical preparations for skin care | SECTION 8 - CANCELLED | — |
| 035 | Advice in the running of establishments as franchises; promoting collaboration with the scientific community to achieve advances in the field of medical and clinical research; advertising and promotional services, namely, marketing scientific projects in medical, pharmaceutical, pharmacological, biochemical and medicine-technological areas on behalf of others | SECTION 8 - CANCELLED | — |
| 042 | Medical and scientific development and research services in the field of medical, biochemical, pharmaceutical and medicine-technological research; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; services of a medical, bacteriological, biochemical laboratory in the field of medicine; services of a medical laboratory; commissioned research and development of new drugs and medicines; scientific contract research; medical contract research; conducting research and development work in medical, pharmaceutical, pharmacological, biochemical and medicine-technological area on behalf of third parties; medical and scientific research, namely, conducting clinical trials and clinical studies | SECTION 8 - CANCELLED | — |
| 044 | Services of a hospital; services of practicing physicians, services of a pharmacist to make up prescriptions | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by mondoBIOTECH AG
- Other trademarks owned by mondoBIOTECH AG
- Other trademarks owned by mondoBIOTECH AG
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SWISSAIR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 11, 2018 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 4, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 16, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 16, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 16, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 16, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 24, 2011 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 10, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 9, 2011 | ALIE | ASSIGNED TO LIE | — |
| Apr 22, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 21, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 21, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 21, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Feb 3, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 2, 2010 | NWAP | NEW APPLICATION ENTERED | — |